Standard
Age-dependent decline of β cell function in type 1 diabetes after diagnosis : a multi-centre longitudinal study. / Barker, Vincent A.; Lauria, A; Schloot, N; Hosszufalusi, N; Ludvigsson, J; Mathieu, Christopher John; Mauricio, D; Nordwall, M; Van der Schueren, B; Mandrup-Poulsen, Thomas; Scherbaum, Wa; Weets, I; Gorus, Fk; Wareham, N; Leslie, Rd; Pozzilli, P.
In:
Diabetes, Obesity and Metabolism Online, Vol. 16, No. 3, 01.10.2013, p. 262-267.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Barker, VA, Lauria, A, Schloot, N, Hosszufalusi, N, Ludvigsson, J, Mathieu, CJ, Mauricio, D, Nordwall, M, Van der Schueren, B
, Mandrup-Poulsen, T, Scherbaum, W, Weets, I, Gorus, F, Wareham, N, Leslie, R & Pozzilli, P 2013, '
Age-dependent decline of β cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study',
Diabetes, Obesity and Metabolism Online, vol. 16, no. 3, pp. 262-267.
https://doi.org/10.1111/dom.12216APA
Barker, V. A., Lauria, A., Schloot, N., Hosszufalusi, N., Ludvigsson, J., Mathieu, C. J., Mauricio, D., Nordwall, M., Van der Schueren, B.
, Mandrup-Poulsen, T., Scherbaum, W., Weets, I., Gorus, F., Wareham, N., Leslie, R., & Pozzilli, P. (2013).
Age-dependent decline of β cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
Diabetes, Obesity and Metabolism Online,
16(3), 262-267.
https://doi.org/10.1111/dom.12216Vancouver
Barker VA, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu CJ et al.
Age-dependent decline of β cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
Diabetes, Obesity and Metabolism Online. 2013 Oct 1;16(3):262-267.
https://doi.org/10.1111/dom.12216Author
Barker, Vincent A. ; Lauria, A ; Schloot, N ; Hosszufalusi, N ; Ludvigsson, J ; Mathieu, Christopher John ; Mauricio, D ; Nordwall, M ; Van der Schueren, B ; Mandrup-Poulsen, Thomas ; Scherbaum, Wa ; Weets, I ; Gorus, Fk ; Wareham, N ; Leslie, Rd ; Pozzilli, P. / Age-dependent decline of β cell function in type 1 diabetes after diagnosis : a multi-centre longitudinal study. In: Diabetes, Obesity and Metabolism Online. 2013 ; Vol. 16, No. 3. pp. 262-267.
Bibtex
@article{e287394f75d64a238488b5cc2e32d431,
title = "Age-dependent decline of β cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study",
abstract = "C-peptide secretion is currently the only available clinical biomarker to measure residual β-cell function in type 1 diabetes. However, the natural history of C-peptide decline after diagnosis can vary considerably dependent upon several variables. We investigated the shape of C-peptide decline over time from type 1 diabetes onset in relation to age at diagnosis, HbA1c levels and insulin dose.",
author = "Barker, {Vincent A.} and A Lauria and N Schloot and N Hosszufalusi and J Ludvigsson and Mathieu, {Christopher John} and D Mauricio and M Nordwall and {Van der Schueren}, B and Thomas Mandrup-Poulsen and Wa Scherbaum and I Weets and Fk Gorus and N Wareham and Rd Leslie and P Pozzilli",
note = "This article is protected by copyright. All rights reserved.",
year = "2013",
month = oct,
day = "1",
doi = "10.1111/dom.12216",
language = "English",
volume = "16",
pages = "262--267",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "3",
}
RIS
TY - JOUR
T1 - Age-dependent decline of β cell function in type 1 diabetes after diagnosis
T2 - a multi-centre longitudinal study
AU - Barker, Vincent A.
AU - Lauria, A
AU - Schloot, N
AU - Hosszufalusi, N
AU - Ludvigsson, J
AU - Mathieu, Christopher John
AU - Mauricio, D
AU - Nordwall, M
AU - Van der Schueren, B
AU - Mandrup-Poulsen, Thomas
AU - Scherbaum, Wa
AU - Weets, I
AU - Gorus, Fk
AU - Wareham, N
AU - Leslie, Rd
AU - Pozzilli, P
N1 - This article is protected by copyright. All rights reserved.
PY - 2013/10/1
Y1 - 2013/10/1
N2 - C-peptide secretion is currently the only available clinical biomarker to measure residual β-cell function in type 1 diabetes. However, the natural history of C-peptide decline after diagnosis can vary considerably dependent upon several variables. We investigated the shape of C-peptide decline over time from type 1 diabetes onset in relation to age at diagnosis, HbA1c levels and insulin dose.
AB - C-peptide secretion is currently the only available clinical biomarker to measure residual β-cell function in type 1 diabetes. However, the natural history of C-peptide decline after diagnosis can vary considerably dependent upon several variables. We investigated the shape of C-peptide decline over time from type 1 diabetes onset in relation to age at diagnosis, HbA1c levels and insulin dose.
U2 - 10.1111/dom.12216
DO - 10.1111/dom.12216
M3 - Journal article
C2 - 24118704
VL - 16
SP - 262
EP - 267
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 3
ER -
